Physician profile
Heather Moore
NPI 1386028785
$913.24
in general payments reported to CMS, 2019-2025
9 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $221 · 2024: $397 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849 · Education: $64.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $848.70 |
| Education | $64.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $413.67 | 2023-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $254.76 | 2024-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $103.76 | 2023 | Mounjaro |
| Exact Sciences Corporation | $47.04 | 2024-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $25.56 | 2025 | |
| Abbvie INC. | $22.22 | 2023 | |
| Astellas Pharma US INC | $18.27 | 2023 | |
| Phathom Pharmaceuticals, INC. | $14.39 | 2024 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.57 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.